Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping
Subtyping
Proteome
Extracellular Vesicles
Cancer Biomarkers
DOI:
10.1038/s42003-019-0570-8
Publication Date:
2019-09-03T10:08:04Z
AUTHORS (8)
ABSTRACT
Extracellular vesicles (EVs) are a potential source of disease-associated biomarkers for diagnosis. In breast cancer, comprehensive analyses EVs could yield robust and reliable subtype-specific that still critically needed to improve diagnostic routines clinical outcome. Here, we show proteome profiles secreted by different cancer cell lines highly indicative their respective molecular subtypes, even more so than the changes within cells. Moreover, detected evidence biological processes pathways, hyperphosphorylated receptors kinases in connection with disease, compiled set protein signatures closely reflect associated pathophysiology. These unique features revealed our work, replicated material, collectively demonstrate differentiate between subtypes prospect use as non-invasive liquid biopsies diagnosis management patients.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (66)
CITATIONS (173)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....